Kangmei Pharmaceutical Co., Ltd. (600518.SS)

Home
600518.SS
Financials

1.93 (CNY) • At close June 13, 2025

Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1997
Revenue Numbers are in millions	5,189.137	4,874.016	4,180.15	4,152.521	5,412.008	11,445.546	17,065.079	17,578.619	21,642.324	18,066.828	15,949.189	13,358.729	11,165.155	6,080.507	3,308.802	2,377.161	1,727.164	1,294.057	825.607	584.614	553.11	464.483	410.98	380.8	352.401	328.78	185.227	81.942
Cost of Revenue Numbers are in millions	4,422.148	4,158.942	3,547.148	3,486.284	5,226.526	9,935.094	11,619.347	10,788.017	15,171.53	12,947.274	11,768.221	9,872.689	8,356.063	4,245.39	2,101.012	1,583.308	1,262.485	956.215	584.964	401.161	382.525	335.363	307.463	303.608	280.302	284.656	160.081	67.278
Gross Profit Numbers are in millions	766.989	715.074	633.002	666.237	185.482	1,510.451	5,445.732	6,790.601	6,470.794	5,119.554	4,180.968	3,486.04	2,809.092	1,835.118	1,207.79	793.853	464.679	337.841	240.643	183.453	170.586	129.12	103.518	77.192	72.099	44.124	25.146	14.664
Gross Profit Ratio Numbers are in millions	0.148	0.147	0.151	0.16	0.034	0.132	0.319	0.386	0.299	0.283	0.262	0.261	0.252	0.302	0.365	0.334	0.269	0.261	0.291	0.314	0.308	0.278	0.252	0.203	0.205	0.134	0.136	0.179
Reseach & Development Expenses Numbers are in millions	42.553	45.618	25.447	9.273	11.359	110.057	142.26	141.412	109.054	77.003	58.015	62.02	62.179	42.045	12.265	0	0	0	0	0	0	0	0	0	0	0	0	0
General & Administrative Expenses Numbers are in millions	115.347	303.659	184.096	205.836	382.813	242.043	382.884	452.762	318.324	173.615	135.295	146.667	145.148	77.717	39.053	74.784	49.849	35.593	29.998	26.89	23.448	18.559	16.164	12.143	11.656	8.917	4.937	3.457
Selling & Marketing Expenses Numbers are in millions	121.006	263.998	466.644	449.837	714.354	1,119.455	1,188.222	1,237.745	557.973	499.306	426.418	383.047	343.845	236.399	193.51	110.206	77.115	56.029	41.332	33.444	29.475	23.82	18.372	17.03	16.369	4.218	2.712	0.969
SG&A Numbers are in millions	236.353	855.442	650.74	655.674	1,097.167	1,361.498	1,571.105	1,690.507	876.296	672.922	561.713	529.713	488.993	314.116	232.563	184.989	126.964	91.623	71.329	60.334	52.923	42.379	34.536	29.173	28.025	13.135	7.65	4.425
Other Expenses Numbers are in millions	503.968	-193.789	970.61	-16,299.498	987.737	1,087.379	-15.525	-236.367	30.943	25.215	40.83	35.093	-4.086	32.28	39.217	8.515	3.548	42.228	18.163	10.846	13.125	7.565	-1.466	3.046	-0.036	-0.007	2.94	-0.001
Operating Expenses Numbers are in millions	791.777	628.407	1,646.797	-15,634.551	2,096.263	2,558.933	2,680.985	2,769.725	1,798.183	1,407.486	1,112.199	985.453	824.069	530.134	349.137	191.697	130.179	96.163	74.201	63.627	55.481	44.57	35.987	30.151	29.013	13.39	8.128	4.806
Operating Income Numbers are in millions	-24.788	86.666	-1,013.794	14,491.915	-1,910.781	-1,048.482	686.921	2,885.597	3,957.723	3,217.93	2,666.417	2,179.336	1,697.025	1,148.149	794.043	573.485	333.78	208.492	148.877	108.853	103.829	76.621	63.076	43.856	37.541	28.078	15.253	9.579
Operating Income Ratio Numbers are in millions	-0.005	0.018	-0.243	3.49	-0.353	-0.092	0.04	0.164	0.183	0.178	0.167	0.163	0.152	0.189	0.24	0.241	0.193	0.161	0.18	0.186	0.188	0.165	0.153	0.115	0.107	0.085	0.082	0.117
Total Other Income Expenses Net Numbers are in millions	59.439	23.7	-886.51	-1,955.584	-542.613	-522.019	-14.439	-91.526	30.082	24.711	40.806	34.674	-269.009	-116.123	-86.247	-16.303	2.828	10.466	-16.967	-11.101	-9.425	-0.364	-5.921	-0.139	-0.036	-0.007	-0.001	-0.001
Income Before Tax Numbers are in millions	34.65	110.367	-2,664.05	8,155.293	-31,033.477	-4,391.08	672.482	2,877.47	3,987.576	3,242.641	2,707.223	2,214.01	1,692.614	1,180.421	833.231	582	337.328	218.958	149.475	108.725	105.679	76.257	57.155	43.716	37.505	28.071	15.252	9.578
Income Before Tax Ratio Numbers are in millions	0.007	0.023	-0.637	1.964	-5.734	-0.384	0.039	0.164	0.184	0.179	0.17	0.166	0.152	0.194	0.252	0.245	0.195	0.169	0.181	0.186	0.191	0.164	0.139	0.115	0.106	0.085	0.082	0.117
Income Tax Expense Numbers are in millions	22.568	6.8	30.27	235.389	62.546	264.128	302.441	733.913	650.817	486.185	421.33	333.597	251.255	175.227	117.709	80.491	42.753	72.849	49.586	36.078	34.469	25.053	13.322	14.56	12.952	2.72	1.584	1.008
Net Income Numbers are in millions	8.574	102.521	-2,694.319	7,917.901	-31,096.023	-4,655.207	374.492	4,100.926	3,340.404	2,756.735	2,285.879	1,879.817	1,441.191	1,005.031	715.523	501.509	294.575	146.109	99.889	72.646	71.21	51.204	43.833	29.157	24.553	20.177	12.673	7.92
Net Income Ratio Numbers are in millions	0.002	0.021	-0.645	1.907	-5.746	-0.407	0.022	0.233	0.154	0.153	0.143	0.141	0.129	0.165	0.216	0.211	0.171	0.113	0.121	0.124	0.129	0.11	0.107	0.077	0.07	0.061	0.068	0.097
EPS Numbers are in millions	0.001	0.01	-0.19	0.57	-6.3	-0.94	0.03	0.39	0.67	0.62	0.52	0.43	0.33	0.23	0.21	0.13	0.082	0.055	0.077	0.032	0.032	0.023	0.02	0.013	0.015	0.016	0.01	0.006
EPS Diluted Numbers are in millions	0.001	0.01	-0.19	0.57	-6.3	-0.94	0.03	0.39	0.67	0.62	0.52	0.43	0.33	0.23	0.21	0.13	0.082	0.055	0.077	0.032	0.032	0.023	0.02	0.013	0.015	0.016	0.01	0.006
EBITDA Numbers are in millions	396.024	512.697	-1,495.807	9,863.277	-28,061.315	-121.466	2,999.995	3,319.381	5,205.584	3,545.902	2,989.498	2,446.81	2,183.229	1,515.677	923.563	649.002	475.718	301.242	204.751	152.442	144.202	107.584	78.944	58.206	50.757	39.351	17.018	9.858
EBITDA Ratio Numbers are in millions	0.076	0.105	-0.358	2.375	-5.185	-0.011	0.176	0.189	0.241	0.196	0.187	0.183	0.196	0.249	0.279	0.273	0.275	0.233	0.248	0.261	0.261	0.232	0.192	0.153	0.144	0.12	0.092	0.12

Kangmei Pharmaceutical Co., Ltd.

SSE:600518.SS Add to watchlist

SSE:600518.SS